This study assesses the readiness and willingness of community pharmacists in England to
deliver the pharmacogenomic (PG) testing service. A survey covering demographics and …

Introduction: Pharmacogenomics reduces the need for trial-and-error prescribing, and the
chances of adverse reactions, and improves patient outcomes. With the cost of PGx testing …

Community pharmacy services have evolved to include medical and pharmaceutical
interventions alongside dispensing. While established pharmacogenomic (PGx) testing is …

Patients obtaining a prescription from a pharmacy expect that the drug will be effective and
have minimal side-effects. Unfortunately, drugs exhibit the desired effect in~ 25–60% of …

Abstract Introduction Pharmacogenomics (PGx) testing services have been delivered
through community pharmacies across the globe, though not yet in the UK. This paper is …

Aim: Over the past several decades, the roles and services of community pharmacists have
expanded beyond traditional medical dispensation and compounding, and include health …

Objective This study assessed pharmacist experiences with delivering pharmacogenetic
(PGx) testing in independent community pharmacies. Methods We conducted a cluster …

Background Despite healthcare professionals (HCP) endorsing the clinical utility of
pharmacogenomics testing, use in clinical practice is limited. Aims To assess …

Background Community pharmacists must be well-equipped to advance
pharmacogenomics services. Nevertheless, limited data is available regarding pharmacists' …

Aim: Perceived knowledge, use and perceptions of pharmacogenomics (PGx) testing were
assessed among healthcare practitioners in North Carolina. Materials & methods: A …